Preview

Medical Genetics

Advanced search

Molecular pathology of the 10q23.3-26.3 chromosome region in glioblastoma

Abstract

Loss of heterozygosity on chromosome 10q is the most frequent genetic alteration in glioblastoma and occurs in up to 80% of cases. Using microsatellite analysis we have determined the frequency of loss of heterozygosity in the 10q23.3-26.3 chromosome region, containing candidate genes PTEN , FGFR2, MKI67 and MGMT , in 124 samples of glioblastoma. Frequency of loss of heterozygosity at the region under investigation equals 62.1%. We have used quantitative microsatellite analysis to establish a quantitative change of copy number of the 10q23.3-26.3 in 64 samples of glioblastoma with identified loss of heterozygosity in 10q23.3-26.3 area. In 37,5% of the samples only one copy of 10q23.3-26.3 chromosome region was found (deletion), in 25,0% two copies were detected (acquired uniparental disomy,). In 37,5% (24/64) of the samples areas of alternation of deletion and acquired uniparental disomy throughout the tested region were identified. Higher frequencies of deletions were characteristic for the proximal part of 10q23.3-26.3 region (PTEN and FGFR2 genes), while acquired uniparental disomy and deletion were equally in the distal part (MGMT gene).

About the Authors

E. A. Alekseeva
Research Centre for Medical Genetics
Russian Federation


A. S. Thanas
Research Centre for Medical Genetics; Pirogov Russian National Research Medical University
Russian Federation


E. V. Prozorenko
I.M. Sechenov First Moscow State Medical University; N.N. Blockin Russian Research Center for Oncology
Russian Federation


A. M. Zaytsev
P.A. Hertsen Research Centre for Oncolology
Russian Federation


M. I. Kurzhupov
P.A. Hertsen Research Centre for Oncolology
Russian Federation


O. N. Kirsanova
P.A. Hertsen Research Centre for Oncolology
Russian Federation


V. V. Rudenko
Research Centre for Medical Genetics
Russian Federation


D. V. Zaletaev
Research Centre for Medical Genetics; Pirogov Russian National Research Medical University; I.M. Sechenov First Moscow State Medical University
Russian Federation


V. V. Strelnikov
Research Centre for Medical Genetics; Pirogov Russian National Research Medical University
Russian Federation


References

1. Dunn GP, Rinne ML, Wykosky J et al. Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev. 2012;26(8):756-784.

2. Hutter A. Overview of Primary Brain Tumors: Pathologic Classification, Epidemiology, Molecular Biology, and Prognostic Markers. Hematol Oncol Clin North Am. 2012 Aug;26(4):715-732.

3. Jesionek-Kupnicka D, Szybka M, Potemski P et al. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Pol J Pathol. 2013 Dec;64(4):168-275.

4. Mizoguchi M, Kuga D, Guan Y et al. Loss of heterozygosity analysis in malignant gliomas. Brain Tumor Pathol. 2011 Jul; 28(3):191-196.

5. Ohgaki H, Kleihues P. Genetic Pathways to Primary and Secondary Glioblastoma. Am J Pathol. 2007 May;170(5):1445-1453.

6. Balesaria S, Brock C, Bower M et al. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer. 1999 Dec;81(8):1371-1377.

7. Tada K, Shiraishi S, Kamiryo T. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: Correlation with patients age and survival. J. Neuroserg. 2001 Oct;95(4):651-659.

8. Crespo I, Tao H, Nieto AB et al. Amplified and Homozygously Deleted Genes in Glioblastoma: Impact on Gene Expression Levels. PLoS One. 2012 Sep;7(9):e46088.

9. Heroux MS, Chesnik MA, Halligan BD et al. Comprehensive characterization of glioblastoma tumor tissues for biomarker identification using mass spectrometry-based label-free quantitative proteomics. Physiol Genomics. 2014 Jul 1;46(13):467-481.

10. Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012 Dec;138(12):1971-1981.

11. Yang Y., Shao N, Luo G et al. Mutations of PTEN Gene in Gliomas Correlate to Tumor Differentiation and Short-term Survival Rate. Anticancer Res. 2010 Mar;30(3):P. 981-985.

12. Katoh M, Nakagama H. FGF Receptors: Cancer Biology and Therapeutics // Med Res Rev. 2014 Mar;34(2):280-300.

13. Nakahara Y, Shiraishi T, Okamoto H et al. Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization. Neuro-Oncology. 2004 Oct;6(4):281-289.

14. Ader I, Delmas C, Skuli N et al. Preclinical evidence that SSR128129E - A novel small-molecule multi-fibroblast growth factor receptor blocker - Radiosensitises human glioblastoma. Eur J Cancer. 2014 Sep;50(13):2351-2359.

15. Arshad H, Ahmad Z, Hasan SH. Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival. Asian Pac J Cancer Prev. 2010;11(6):1637-1640.

16. Hegi ME, Liu L, Herman JG et al. Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity. J Clin Oncol. 2008 Sep 1;26(25):4189-4199.

17. Стрельников ВВ, Малышева АС, Шубина МВ и др. Делеции области расположения гена MGMT на хромосоме 10q26.3. Молекулярная медицина. 2011;(2):28-31.

18. Ginzinger DG, Godfrey TE, Nigro J et al. Measurement of DNA Copy Number at Microsatellite Loci Using Quantitative PCR Analysis. Cancer Res. 2000 Oct;60(19):5405-5409.

19. Nigro JM, Takahashi MA, Ginzinger DG et al. Detection of 1p and 19q Loss in Oligodendroglioma by Quantitative Microsatellite Analysis, a Real-Time Quantitative Polymerase Chain Reaction Assay. Am J Pathol. 2001 Apr;158(4):1253-1262.

20. Алексеева Е.А., Танас А.С., Прозоренко Е.В. и др. Анализ аллельного дисбаланса при глиобластоме: новые хромосомные участки потери гетерозиготности и новые гены-кандидаты. Медицинская генетика. 2014;(11):41-46.

21. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA. 1971 Apr.;68(4): 820-823.

22. Yin D, Ogawa S, Kawamata N et al. High Resolution Genomic Copy Number Profiling of Glioblastoma Multiforme by Single Nucleotide Polymorphism DNA Microarray.Mol. Cancer Res. 2009 May; 7(5): 665-677.


Review

For citations:


Alekseeva E.A., Thanas A.S., Prozorenko E.V., Zaytsev A.M., Kurzhupov M.I., Kirsanova O.N., Rudenko V.V., Zaletaev D.V., Strelnikov V.V. Molecular pathology of the 10q23.3-26.3 chromosome region in glioblastoma. Medical Genetics. 2016;15(12):14-22. (In Russ.)

Views: 751


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-7998 (Print)